Spencer Hoover, Ph.D., is an experienced independent consultant with over 15 years of industry experience including directing scientific teams across cell and gene therapy, in vitro diagnostics, and CDMO operations. He specializes in Technical Operations strategy and planning, with a proven track record of designing phase-appropriate CMC strategies, implementing data-driven forecasting models, and guiding organizations through complex technical challenges. His expertise spans automation of molecular and cell-based assays, process and analytical development, and risk-based scenario planning to enable efficient and commercially viable therapeutic programs.